Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
The American Review of Respiratory Disease
|
February 1, 1990
Lung microvascular transport properties measured by multiple indicator dilution methods in patients with adult respiratory distress syndrome. A comparison between patients reversing respiratory failure and those failing to reverse
T R Harris, G R Bernard, K L Brigham, et al.
The New England Journal of Medicine
|
December 17, 1987
High-dose corticosteroids in patients with the adult respiratory distress syndrome
G R Bernard, J M Luce, C L Sprung, et al.
Critical Care Medicine
|
September 20, 1997
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage
D J Cook, P C Hébert, D K Heyland, et al.
Intensive Care Medicine
|
February 27, 2017
The status of intensive care medicine research and a future agenda for very old patients in the ICU
H Flaatten, D W de Lange, A Artigas, et al.
The Journal of Infectious Diseases
|
December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels
C H Wortel, M A von der Möhlen, S J van Deventer, et al.
Intensive Care Medicine
|
May 1, 1994
HA-1A in septic patients with ARDS: results from the pivotal trial
L M Bigatello, R E Greene, C L Sprung, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
September 28, 2022
End-of-life practices in 11 German intensive care units : Results from the ETHICUS-2 study
C Denke, U Jaschinski, R Riessen, et al.
The Journal of Hospital Infection
|
March 8, 2005
Increased risk of bloodstream and urinary infections in intensive care unit (ICU) patients compared with patients fitting ICU admission criteria treated in regular wards
G Mnatzaganian, N Galai, C L Sprung, et al.
The New England Journal of Medicine
|
February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group
E J Ziegler, C J Fisher, C L Sprung, et al.
Critical Care Medicine
|
August 1, 1994
An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody
D H Kett, A A Quartin, C L Sprung, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
The American Review of Respiratory Disease
|
February 1, 1990
Lung microvascular transport properties measured by multiple indicator dilution methods in patients with adult respiratory distress syndrome. A comparison between patients reversing respiratory failure and those failing to reverse
T R Harris, G R Bernard, K L Brigham, et al.
The New England Journal of Medicine
|
December 17, 1987
High-dose corticosteroids in patients with the adult respiratory distress syndrome
G R Bernard, J M Luce, C L Sprung, et al.
Critical Care Medicine
|
September 20, 1997
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage
D J Cook, P C Hébert, D K Heyland, et al.
Intensive Care Medicine
|
February 27, 2017
The status of intensive care medicine research and a future agenda for very old patients in the ICU
H Flaatten, D W de Lange, A Artigas, et al.
The Journal of Infectious Diseases
|
December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels
C H Wortel, M A von der Möhlen, S J van Deventer, et al.
Intensive Care Medicine
|
May 1, 1994
HA-1A in septic patients with ARDS: results from the pivotal trial
L M Bigatello, R E Greene, C L Sprung, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
September 28, 2022
End-of-life practices in 11 German intensive care units : Results from the ETHICUS-2 study
C Denke, U Jaschinski, R Riessen, et al.
The Journal of Hospital Infection
|
March 8, 2005
Increased risk of bloodstream and urinary infections in intensive care unit (ICU) patients compared with patients fitting ICU admission criteria treated in regular wards
G Mnatzaganian, N Galai, C L Sprung, et al.
The New England Journal of Medicine
|
February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group
E J Ziegler, C J Fisher, C L Sprung, et al.
Critical Care Medicine
|
August 1, 1994
An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody
D H Kett, A A Quartin, C L Sprung, et al.
Page
of 13